logo

For the Inventor, By the Inventor

Ballerup, Denmark

Jørgen Scheel-Krüger

This inventor holds 13 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Neurosearch A/s, Saniona A/s. Active years: 2005-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jørgen Scheel-Krüger. Retrieved from https://idiyas.com/inventor/jørgen-scheel-krüger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 23.1

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Ballerup, DK (2008 - 2011)
  • Glostrup, DK (2005 - 2016)

Company Filing History:

goldMedal12 out of 206 
 
Neurosearch A/s
 patents
silverMedal1 out of 18 
 
Saniona A/s
 patents

Years Active: 2005-2016

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 9457018 - Method for combating adverse effects arising from antipsychotic treatment (2016-10-04),
2. 7973082 - Substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors (2011-07-05),
3. 7915419 - Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-03-29),
4. 7888358 - 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-02-15),
5. 7713990 - 3,8-substituted 8-AZA-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors (2010-05-11),
6. 7696350 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2010-04-13),
7. 7547788 - Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2009-06-16),
8. 7524958 - Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2009-04-28),
9. 7459464 - Triple monoamine reuptake inhibitors for the treatment of chronic pain (2008-12-02),
10. 7407970 - 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2008-08-05),
11. 7381733 - Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases (2008-06-03),
12. 7247643 - 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2007-07-24),
13. 6943159 - Compounds and their use as positive AMPA receptor modulators (2005-09-13),

Title: The Innovative Journey of Jørgen Scheel-Krüger

Introduction

Jørgen Scheel-Krüger is a renowned inventor based in Ballerup, Denmark, known for his significant contributions to the field of pharmacology and his remarkable portfolio of 13 patents. His inventions focus on addressing critical health issues, particularly related to mental health treatment.

Latest Patents

Among his latest innovations, Scheel-Krüger has developed a groundbreaking method for combating adverse effects arising from antipsychotic treatment. This invention encompasses a novel approach utilizing a combination of specific compounds and antipsychotic drugs to improve patient outcomes. Furthermore, he has worked on novel substituted aryloxy alkylamines that serve as monoamine neurotransmitter re-uptake inhibitors. This invention not only discusses the therapeutic applications of these compounds but also includes pharmaceutical compositions that incorporate them, showcasing his dedication to advancing medical therapies.

Career Highlights

Throughout his career, Jørgen Scheel-Krüger has made his mark in the pharmaceutical industry, having worked with prominent companies such as NeuroSearch A/S and Saniona A/S. His experience in these organizations has allowed him to collaborate on impactful research and development projects, ultimately leading to innovative solutions in the realm of mental health.

Collaborations

His work has also involved fruitful collaborations with notable colleagues such as Gunnar M. Olsen and Elsebet Østergaard Nielsen. These partnerships highlight the importance of teamwork in the innovation process, as they collectively strive to enhance therapeutic options in the market.

Conclusion

Jørgen Scheel-Krüger stands as a prolific inventor whose contributions to pharmacology have the potential to transform treatment options for individuals facing mental health challenges. With his impressive array of patents and collaborative efforts, he continues to push the boundaries of innovation, making significant strides in the pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…